期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

小剂量安体舒通与二甲双胍联用治疗多囊卵巢综合征 被引量：5

原文传递
导出
摘要 多囊卵巢综合征（PCOS）是育龄妇女常见疾病，患病率为育龄妇女的5％～10％，闭经女性的20％，多毛、高雄激素血症女性的80％，且常伴肥胖、胰岛素抵抗、高血压、脂质代谢紊乱，已成为多学科关注的常见病。
作者 陈名道
机构地区 上海市内分泌代谢病研究所
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第11期1002-1002,共1页 Chinese Journal of Endocrinology and Metabolism
关键词 多囊卵巢综合征 联用治疗 二甲双胍 安体舒通 小剂量 高雄激素血症 脂质代谢紊乱 育龄妇女
分类号 R711.75 [医药卫生—妇产科学]
  • 相关文献

参考文献4

  • 1Escobar-Morreale HF. Polycystic ovary syndrome: treatmen| strat:gies and management. Expert Opin Phamacother, 2008,9:2995-3008.
  • 2陶弢,刘伟,赵爱民,李圣贤,郑俊,王丽华,周佳雯,黄融,张萍.不同表型多囊卵巢综合征患者代谢综合征患病特点及风险研究[J].中华内分泌代谢杂志,2013,29(3):200-205. 被引量：40
  • 3Costello M, Shrestha B, Eden J, et al. Insulin-sensitising drags versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endomettial cancer in p.lyeystic ovary syndrome. Cochrane Database Syst Rev, 2007,1 :CD005552.
  • 4Ganie MA, Khurana ML, Nisar S, et al. Improved efficacy of low-dose spironolactone and metformin combination than either drugs alone in lJle management of women with polycystic ovary syndrome ( PCOS ) : a six- month, open-label randomized study. J Clin Endoeziuol Metab , 2013, 98 : 3599-3607.

二级参考文献18

  • 1Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos : hormonal and metabolic profile. J Clin Endocrinol Metab, 1999,84:4006-4011.
  • 2Ovalle F, Azziz R. Insulin resistance, polycystie ovary syndrome, and type 2 diabetes mellitus. Fertil Steril, 2002,77 : 1095-1105.
  • 3Samy N, Hashim M, Sayed M, et al. Clinical significance of inflammatory markers in polycystic ovary syndrome : their relationship to insulin resistance and body mass index. Dis Markers, 2009,26:163- 170.
  • 4Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnosis criteria and long-tem health risks zlated to polycystic ovary Syndrome. Fertil Steril, 2004, 81 : 19-25.
  • 5Mehrabian F, Khani B, Kelishadi R, et al. The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females. J Res Med Sci, 2011,16:763-769.
  • 6Goverde A J, van Koert A J, Eijkemans MJ, et al. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod, 2009,24:710-717.
  • 7Teede H, Deeks A, Moran L. Polycystic ovarian syndrome : a complex condition with psychological, reproductive and metabolic manifestations, that impacts on health across the lifespan. BMC Mcd, 2010,8:41.
  • 8Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev, 1997,18 : 774-800.
  • 9Essah PA, Wickham EP, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. Clin Obstet Gynecol, 2007,50:205-225.
  • 10Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab, 2006,91:492-497.

共引文献39

同被引文献51

引证文献5

二级引证文献42

中华内分泌代谢杂志
2013年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部